Company Registration No. 14430064 (England and Wales)
ATMOSPHARMA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
Celixir House
Stratford Business & Technology Park
Innovation Way, Banbury Road
Stratford-upon-Avon
Warwickshire
United Kingdom
CV37 7GZ
ATMOSPHARMA LIMITED
CONTENTS
Page
Company information
Balance sheet
1
Notes to the financial statements
2 - 3
ATMOSPHARMA LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
-
0
72
Cash at bank and in hand
372
686
372
758
Creditors: amounts falling due within one year
4
(58,587)
(52,831)
Net current liabilities
(58,215)
(52,073)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(58,315)
(52,173)
Total equity
(58,215)
(52,073)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 3 December 2025 and are signed on its behalf by:
Mrs M J Pearson
Prof D C Spanswick
Director
Director
Company registration number 14430064 (England and Wales)
ATMOSPHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -
1
Accounting policies
Company information

Atmospharma Limited is a private company limited by shares incorporated in England and Wales. The registered office is Band Hatton Button LLP, 53-55 Butts Road, Earlsdon Park, Coventry, West Midlands, England, CV 1 3BH.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
72
ATMOSPHARMA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -
4
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
58,587
52,831
2025-10-312024-11-01falsefalsefalse03 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMrs Melissa J PearsonProf D C Spanswick144300642024-11-012025-10-31144300642025-10-31144300642024-10-3114430064core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-3114430064core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3114430064core:ShareCapital2025-10-3114430064core:ShareCapital2024-10-3114430064core:RetainedEarningsAccumulatedLosses2025-10-3114430064core:RetainedEarningsAccumulatedLosses2024-10-3114430064bus:Director12024-11-012025-10-3114430064bus:Director22024-11-012025-10-31144300642023-11-012024-10-3114430064core:CurrentFinancialInstruments2025-10-3114430064core:CurrentFinancialInstruments2024-10-3114430064bus:PrivateLimitedCompanyLtd2024-11-012025-10-3114430064bus:SmallCompaniesRegimeForAccounts2024-11-012025-10-3114430064bus:FRS1022024-11-012025-10-3114430064bus:AuditExemptWithAccountantsReport2024-11-012025-10-3114430064bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP